Certificate marks on outer pakage to be granted.

Published: 2003-07-08 06:59:00

Updated: 2003-07-08 06:59:00

The KFDA may allow for the duplicate drug proven of its bio-equivalency to the original one to show a certificate mark in letter or design on the outer packages in order to endorse its product credibility and to boost more substituted dispensing.

This plan will be reflected to the working rule...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK